Could a donated corneal lens fix farsightedness after cataract surgery?

NCT ID NCT04692012

Ongoing Disease control Sponsor: Eye Hospital Pristina Kosovo Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether implanting a fresh, donated corneal lenticule — a thin layer of corneal tissue — can safely correct residual farsightedness in people who already have an artificial lens implant after cataract surgery. The procedure uses a femtosecond laser to create a pocket in the cornea and insert the donor tissue. The goal is to improve visual acuity without the risks associated with LASIK or refractive lens exchange.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fresh corneal myopic lenticule implantation (ReLex-SMILE surgery)
What this could lead to: If successful, this could offer a safer surgical option for correcting residual farsightedness in patients with artificial lens implants, avoiding complications of LASIK or lens exchange.
What could go wrong: This is a small, early-stage trial with only 34 participants. Risks include infection, refractive errors, and the need for additional procedures like YAG-laser capsulotomy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERMETROPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperopia myopia Pseudophakia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERMETROPIA MYOPIA PSEUDOPHAKIA

Contacts and locations

Locations

Eye Hospital Pristina

Pristina, 10000, Kosovo

More trials for these conditions

Other studies related to the condition(s) this trial covers.